Altis Labs
AI-powered prognosis platform for clinical oncology trials.
Altis Labs is a biotech & life sciences company based in Toronto, CA, founded in 2019. It has raised $25 million in disclosed funding. Its latest round was a Series A of $25 million in September 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $25M across 1 round. Computed only from sourced rounds.
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| $25M | Series A | OrbiMed, Qiming Venture Partners USA | — | Biotech & Life Sciences | 1 |
- Altis Labs$25M
Led by OrbiMed, Qiming Venture Partners USA
Investors
Questions and answers
What does Altis Labs do?
AI-powered prognosis platform for clinical oncology trials.
How much has Altis Labs raised?
Altis Labs has raised $25 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Altis Labs?
Investors in Altis Labs include OrbiMed and Qiming Venture Partners USA.
When and where was Altis Labs founded?
Altis Labs was founded in 2019 and is based in Toronto, CA.
Timeline
Founded
Sources
- 1.Altis Labs raises $25 million USD Series A to expand AI for cancer trials — BetaKit, Sep 21, 2026